Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PPARGC1A and ADIPOQ polymorphisms are associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity.

Cancer biomarkers : section A of Disease markers - 4 Jul 2017

Canto Patricia, Granados Jesús Benítez, Feria-Bernal Guillermo, Coral-Vázquez Ramón Mauricio, García-García Eduardo, Tejeda María Elena, Tapia André, Rojano-Mejía David, Méndez Juan Pablo

Abstract excerpt

BACKGROUND: Obesity constitutes a risk factor for the development of aggressive forms of prostate cancer. It has been proposed, that prostate cancer has a genetic predisposition and that PPARGC1A and ADIPOQ polymorphisms play a role in the development of this condition. OBJECTIVE: To analyse the association of two PPARGC1A and ADIPOQ polymorphisms as well as their haplotypes, with the development of aggressive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mexico
Share to Adiponectin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Gene Frequency

Share to Obesity

Share to Overweight

Share to Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 28453464
DOI: 10.3233/CBM-160467
PMCID: PMC13020731

Genes

ADIPOQ
PPARGC1A

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PPARGC1A and ADIPOQ polymorphisms are associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity.PMID 28453464Read ↗

Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo men.Semantic proximity Read ↗

Genetic polymorphisms in leptin, adiponectin and their receptors affect risk and aggressiveness of prostate cancer: evidence from a meta-analysis and pooled-review.Semantic proximity Read ↗

Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping.Semantic proximity Read ↗

Genetic predisposition to metabolically unfavourable adiposity and prostate cancer risk: A Mendelian randomization analysis.Semantic proximity Read ↗

Association between metabolic obesity phenotypes and the risk of developing prostate cancer: a propensity score matching study based on Xinjiang.Semantic proximity Read ↗

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.Semantic proximity Read ↗

Inflammation polymorphisms and prostate cancer risk in Jamaican men: Role of obesity/body size.Semantic proximity Read ↗

Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.Semantic proximity Read ↗

Genetic variations of the ADIPOQgene and risk of prostate cancer in Chinese Han men.Semantic proximity Read ↗

Prostate cancer genetic propensity risk score may modify the association between this tumour and type 2 diabetes mellitus (MCC-Spain study).Semantic proximity Read ↗

Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans.Semantic proximity Read ↗

A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.